AlphaYou
Overview
Key stats
Fundamentals Sep 10- Open
- $53.16
- 52-wk high
- $55.72
- High
- $53.71
- 52-wk low
- $25.36
- Low
- $51.97
- Prev close
- $53.73
- Mkt cap
- $2.70B
- P/E
- 252.5x
- Volume
- 1.66M
- Fwd P/E
- 212.8x
- Beta
- 1.26
- P/S
- 4.7x
- P/B
- 5.3x
- Profit margin
- +1.8%
- Op margin
- +6.3%
- ROE
- +2.1%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsSmart money
Earnings
Earnings came in $0.15 a share above what analysts expected.
Earnings per share
$0.03 expected
Reports Oct 27, 2026, in 47 days
EPS expected
-$0.03 to $0.04
Revenue expected
9 analysts
Estimate drift
Change in 30 days
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $134.3M | $140.5M | $141.2M | $153.6M |
| Cost of what it sold | $32.9M | $35.9M | $31.9M | $35.0M |
| Gross profit | $101.3M | $104.6M | $109.3M | $118.6M |
| What it spent | ||||
| Research and development | $22.9M | $22.7M | $24.2M | $26.4M |
| Sales and admin | $78.2M | $78.3M | $84.5M | $82.6M |
| Total operating expenses | $101.1M | $101.1M | $108.8M | $109.0M |
| What was left | ||||
| Operating profit | $208.0K | $3.5M | $526.0K | $9.7M |
| Interest on debt | $2.9M | $1.5M | $1.3M | $1.3M |
| Profit before tax | -$86.0K | $2.4M | $394.0K | $9.4M |
| Tax | $181.0K | $604.0K | $286.0K | $471.0K |
| Net profit | -$267.0K | $1.8M | $108.0K | $9.0M |
| EBITDA | $8.0M | $9.0M | $7.0M | $3.2M |
Technicals
Price structure
This stock is in a strong uptrend, and looks overbought after a fast run-up.
Trend
Strong uptrend
85 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
News
What the news says
Coverage is bullish
Tone of tracked coverage
How Atricure Inc. (ATRC) Affects Rotational Strategy Timing
BullishSep 9AtriCure CTO Privitera Sells 7,763 Shares at $52.50 Each (NASDAQ: ATRC)
NeutralSep 8AtriCure CTO Salvatore Privitera Sells 7,763 Shares via 10b5-1 Trading Plan
NeutralSep 4Atricure CTO Salvatore Privitera sells $407,557 in stock
NeutralSep 4Atricure stock hits 52-week high at $50.00
BullishSep 2AtriCure to Participate in the 2026 Wells Fargo Health Care Conference
NeutralAug 28Is AtriCure (ATRC) Outperforming Other Medical Stocks This Year?
BullishAug 27Piper Sandler raises AtriCure stock price target on quality measure
BullishAug 27
Macro
10 macro signals shaping ATRC right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results